Solvonis Therapeutics plc Stock
Stocks
SVNS
GB00BMD1Z199
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
London S.E.
11:35:04 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.1250 GBX | 0.00% |
|
-16.67% | -59.68% |
| 08-25 | Solvonis Therapeutics placing raises GBP1.3 million | AN |
| 08-25 | WINNERS & LOSERS: Galileo celebrates new copper mineralisation find | AN |
| Market Cap | 8.51M 11.54M 9.94M 9.32M 16.03M 1.1B 16.08M 111M 43.14M 557M 43.31M 42.37M 1.85B | P/E 2026 * |
-2.55x | P/E 2027 * | -2.5x |
|---|---|---|---|---|---|
| Enterprise Value | 6.64M 9M 7.75M 7.27M 12.5M 860M 12.54M 86.24M 33.65M 434M 33.78M 33.04M 1.44B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
53.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -16.67% | ||
| Current month | -1.96% | ||
| 1 month | -10.71% | ||
| 3 months | -50.00% | ||
| 6 months | -45.65% | ||
| Current year | -59.68% |
| 1 week | 0.12 |  | 0.13 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.33 |
| 1 year | 0.12 | | 0.4 |
| 3 years | 0.1 | | 2.65 |
| 5 years | 0.1 | | 22.46 |
| 10 years | 0.1 | | 22.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
CEO | Chief Executive Officer | 50 | 2024-05-01 |
Ryan Neates
DFI | Director of Finance/CFO | 34 | - |
David Nutt
CTO | Chief Tech/Sci/R&D Officer | - | 2025-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
BRD | Director/Board Member | 50 | 2024-05-01 |
Nicholas Nelson
CHM | Chairman | 61 | 2024-03-14 |
Dennis Purcell
CHM | Chairman | 71 | 2024-09-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/10/24 | Free | Director | 10,500,000 | 8.4159% | ||
| 7/10/24 | Free | Responsable ventes & marketing | 8,694,000 | 6.9684% | ||
| 7/10/24 | Free | Director | 10,500,000 | 8.4159% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -16.67% | -54.55% | -94.44% | 11.54M | |
| -0.77% | -1.53% | +1.37% | +18.39% | 50.47B | |
| -1.71% | -3.95% | +414.09% | +498.23% | 44.56B | |
| -1.24% | -0.58% | +40.82% | +16.22% | 43.08B | |
| -2.81% | -4.55% | +6.94% | +71.08% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.08% | -3.91% | +25.87% | +120.44% | 16.77B | |
| +5.61% | +4.50% | - | - | 16.28B | |
| -0.72% | -1.91% | +10.59% | +26.43% | 14.58B | |
| -1.15% | -3.28% | +79.10% | +39.64% | 13.92B | |
| Average | -0.42% | -2.91% | +60.41% | +82.69% | 27.46B | |
| Weighted average by Cap. | -0.94% | -1.21% | +88.67% | +121.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.57M -4.84M -4.17M -3.91M -6.73M -463M -6.75M -46.4M -18.1M -234M -18.17M -17.78M -774M | -4.01M -5.44M -4.69M -4.39M -7.55M -520M -7.58M -52.12M -20.33M -262M -20.41M -19.97M -870M |
| Net Debt | -1.87M -2.54M -2.19M -2.05M -3.53M -243M -3.54M -24.34M -9.5M -122M -9.53M -9.32M -406M | -6.92M -9.38M -8.08M -7.58M -13.03M -897M -13.07M -89.92M -35.08M -453M -35.22M -34.45M -1.5B |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | GBX 0.1250 | 0.00% | 15,654,585 |
| 26-08-27 | GBX 0.1250 | 0.00% | 20,710,574 |
| 26-08-26 | GBX 0.1250 | +2.46% | 4,212,561 |
| 26-08-25 | GBX 0.1220 | -12.86% | 168,877,452 |
| 26-08-24 | GBX 0.1400 | -6.67% | 9,467,000 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001250GBP
Average target price
0.0170GBP
Spread / Average Target
+1,260.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SVNS Stock
Select your edition
All financial news and data tailored to specific country editions
